Harrington, Michael G.

Blood-brain barrier breakdown in the aging human hippocampus

Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron

Barrier Structure and Function StudiesCerebrospinal fluid and hydrocephalus

Cited by 2,102

Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction

Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., et al. (2019) · Nature Medicine

Barrier Structure and Function StudiesAlzheimer's disease research and treatments

Cited by 1,728

APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline

Montagne, A., Nation, D. A., Sagare, A. P., Barisano, G., Sweeney, M. D., Chakhoyan, A., Pachicano, M., Joe, E., Nelson, A. R., D’Orazio, L. M., et al. (2020) · Nature

Barrier Structure and Function StudiesAlzheimer's disease research and treatments

Cited by 1,281

Vascular dysfunction—The disregarded partner of Alzheimer's disease

Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments

Cited by 711

ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes

Rawat, V., Wang, S., Sima, J., Bar, R., Liraz, O., Gundimeda, U., Parekh, T., Chan, J., Johansson, J. O., Tang, C., et al. (2019) · The Journal of Neuroscience

Alzheimer's disease research and treatmentsCholesterol and Lipid Metabolism

Cited by 165

Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods

Fonteh, A. N., Harrington, R. J., Huhmer, A. F., Biringer, R. G., Riggins, J. N., & Harrington, M. G. (2006) · Disease Markers

Metabolomics and Mass Spectrometry StudiesSphingolipid Metabolism and Signaling

Cited by 113

Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis

Yassine, H. N., Feng, Q., Azizkhanian, I., Rawat, V., Castor, K., Fonteh, A. N., Harrington, M. G., Zheng, L., Reed, B. R., DeCarli, C., et al. (2016) · JAMA Neurology

Fatty Acid Research and HealthDementia and Cognitive Impairment Research

Cited by 94

ABCA1‐Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease

Yassine, H. N., Feng, Q., Chiang, J., Petrosspour, L. M., Fonteh, A. N., Chui, H. C., & Harrington, M. G. (2016) · Journal of the American Heart Association

Alzheimer's disease research and treatmentsCholesterol and Lipid Metabolism

Cited by 80

Cerebrospinal fluid sodium rhythms

Harrington, M. G., Salomon, R. M., Pogoda, J. M., Oborina, E., Okey, N., Johnson, B., Schmidt, D., Fonteh, A. N., & Dalleska, N. F. (2010) · Cerebrospinal Fluid Research

Migraine and Headache StudiesCircadian rhythm and melatonin

Cited by 56

Alpha desynchronization/synchronization during working memory testing is compromised in acute mild traumatic brain injury (mTBI

Arakaki, X., Shoga, M., Li, L., Zouridakis, G., Tran, T., Fonteh, A. N., Dawlaty, J., Goldweber, R., Pogoda, J. M., & Harrington, M. G. (2018) · PLOS ONE

Traumatic Brain Injury ResearchTraumatic Brain Injury and Neurovascular Disturbances

Cited by 23